RecruitingNot ApplicableNCT02431845

Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder

Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive


Sponsor

Severance Hospital

Enrollment

200 participants

Start Date

Jan 1, 2013

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine whether pharmaco(epi)genetic study predict selective serotonin reuptake inhibitor (SSRI) responsiveness in advance before the appearance of the drug effect until 4 months(16 weeks), 6 months, and 1 year after administration of SSRIs.


Eligibility

Min Age: 19 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is analyzing genetic, protein, and gut bacteria patterns in people with obsessive-compulsive disorder (OCD) to better understand what biological factors drive the condition and identify potential new treatment targets. **You may be eligible if...** - You are between 19 and 70 years old - You have been diagnosed with OCD according to standard psychiatric guidelines - You are either not currently taking any psychiatric medication, or you have been off all psychiatric medications for at least 3 months **You may NOT be eligible if...** - You have a neurological disorder (such as epilepsy or a movement disorder) - You have a psychotic disorder (such as schizophrenia) - You have used alcohol or drugs heavily in the past 6 months - You have any evidence of another brain disease Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSSRIs

usual dose SSRI for obsessive-compulsive disorder, i.e. fluoxetine 40\~80 mg dose equivalents


Locations(1)

Yonsei Univ. Health System Severance Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02431845


Related Trials